John Marriott
- Geriatrics and Gerontology top 1%
- Pharmaceutical Practices and Patient Outcomes 17
-
- Antibiotic Use and Resistance 9
- Family Practice top 5%
-
- Pharmaceutical studies and practices 17
- Toxicology top 5%
- Pharmacovigilance and Adverse Drug Reactions 6
-
- Healthcare Systems and Technology 12
-
- Nursing Roles and Practices 8
-
- Health Systems, Economic Evaluations, Quality of Life 7
- Pharmaceutical Economics and Policy 7
- Co-authors
- Hannah BatchelorAlison RushtonTim NobletAdam MackridgeChris CurtisR E FernerKeith WilsonJanice M. Marshall
- Journals
- International Journal of Pharmacy Practice (9 papers)PLoS ONE (9 papers)Archives of Disease in Childhood (7 papers)
- Partner nations
- United KingdomAustraliaSaudi Arabia
In The Last Decade
John Marriott
93 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 164
- Geriatrics and Gerontology 254
- Applied Microbiology and Biotechnology 115
- Family Practice 71
- Pediatrics, Perinatology and Child Health 496
- Toxicology 68
Countries citing papers authored by John Marriott
This map shows the geographic impact of John Marriott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Marriott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Marriott more than expected).
Fields of papers citing papers by John Marriott
This network shows the impact of papers produced by John Marriott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Marriott. The network helps show where John Marriott may publish in the future.
Co-authorship network
The 25 scholars most cited alongside John Marriott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 4 | |
| 2 | 2021 | 11 | |
| 3 | 2021 | 11 | |
| 4 | 2021 | 3 | |
| 5 | 2020 | 10 | |
| 6 | 2019 | 57 | |
| 7 | 2019 | 6 | |
| 8 | 2019 | 10 | |
| 9 | 2019 | 7 | |
| 10 | 2018 | 33 | |
| 11 | 2017 | 69 | |
| 12 | 2017 | 44 | |
| 13 | 2016 | 6 | |
| 14 | 2015 | 7 | |
| 15 | 2010 | 41 | |
| 16 | Mixed evidence of an early market entry in the pharmaceutical business market | 2008 | 1 |
| 17 | A comparison of antibiotic prescribing indicators and medicines management scoring in secondary care | 2003 | 2 |
| 18 | The use of digital video to support extemporaneous skills in pharmacy practice | 2002 | 1 |
| 19 | The metropolitan poor : semi-factual accounts, 1795-1910 | 1999 | 1 |
| 20 | 1987 | 5 |
About John Marriott
John Marriott is a scholar working on Applied Microbiology and Biotechnology, Geriatrics and Gerontology and Toxicology, having authored 100 papers that have together received 1.6k indexed citations. Recurring topics across this work include Pharmaceutical studies and practices (17 papers), Pharmaceutical Practices and Patient Outcomes (17 papers), Healthcare Systems and Technology (12 papers), Antibiotic Use and Resistance (9 papers), Nursing Roles and Practices (8 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers), Pharmaceutical Economics and Policy (7 papers) and Pharmacovigilance and Adverse Drug Reactions (6 papers). The work is most often cited by research in Geriatrics and Gerontology (254 citations), Applied Microbiology and Biotechnology (115 citations) and Family Practice (71 citations). John Marriott has collaborated with scholars based in United Kingdom, Australia and Saudi Arabia. Frequent co-authors include Hannah Batchelor, Alison Rushton, Tim Noblet, Adam Mackridge, Chris Curtis, R E Ferner, Keith Wilson, Janice M. Marshall, James Hodson and Chris Langley. Their work appears in journals such as International Journal of Pharmacy Practice, PLoS ONE, Archives of Disease in Childhood, British Journal of Clinical Pharmacology and BMJ Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.